EP1108068A4 - T-typ kalzium kanal - Google Patents

T-typ kalzium kanal

Info

Publication number: EP1108068A4
Authority: EP; European Patent Office
Prior art keywords: type; calcium channel; calcium; channel
Prior art date: 1998-08-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP99969121A

Other languages

English (en)

French (fr)

Other versions

EP1108068A1 (de

Inventor

Ming Li

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

University of South Alabama

Original Assignee

University of South Alabama

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-08-26

Filing date

1999-08-26

Publication date

2002-12-04

1999-08-26 Application filed by University of South Alabama filed Critical University of South Alabama

2001-06-20 Publication of EP1108068A1 publication Critical patent/EP1108068A1/de

2002-12-04 Publication of EP1108068A4 publication Critical patent/EP1108068A4/de

Status Withdrawn legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Diabetes (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Toxicology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Hematology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Veterinary Medicine (AREA)
Cell Biology (AREA)
Immunology (AREA)
Obesity (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)
Enzymes And Modification Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

EP99969121A 1998-08-26 1999-08-26 T-typ kalzium kanal Withdrawn EP1108068A4 (de)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US9800498P	1998-08-26	1998-08-26
US98004P		1998-08-26
US11739999P	1999-01-27	1999-01-27
US117399P		1999-01-27
PCT/US1999/019675 WO2000015845A1 (en)	1998-08-26	1999-08-26	T-type calcium channel

Publications (2)

Publication Number	Publication Date
EP1108068A1 EP1108068A1 (de)	2001-06-20
EP1108068A4 true EP1108068A4 (de)	2002-12-04

Family

ID=26793874

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP99969121A Withdrawn EP1108068A4 (de)	1998-08-26	1999-08-26	T-typ kalzium kanal

Country Status (5)

Country	Link
EP (1)	EP1108068A4 (de)
JP (1)	JP2002525077A (de)
AU (1)	AU6021799A (de)
CA (1)	CA2340586A1 (de)
WO (1)	WO2000015845A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2001235364A1 (en)	2000-02-25	2001-09-03	Novo-Nordisk A/S	Tetrahydronaphtalene derivatives and their use
WO2001062740A1 (en) *	2000-02-25	2001-08-30	South Alabama Medical Science Foundation	Mibefradil analogues and their use
US7166603B2 (en)	2003-07-23	2007-01-23	Bristol-Myers Squibb Co.	Dihydropyrimidone inhibitors of calcium channel function
US7157461B2 (en)	2003-07-23	2007-01-02	Bristol-Myers Squibb Co.	Substituted dihydropyrimidine inhibitors of calcium channel function
US7504431B2 (en)	2004-04-16	2009-03-17	Bristol-Myers Squibb Company	Sulfonyl amide inhibitors of calcium channel function
EP1632245A1 (de) *	2004-09-02	2006-03-08	Technische Universität Dresden Medizinische Fakultät Carl Gustav Carus	ICA512 koppelt Insulinsekeretion und Genexpression in Beta-Zellen
DK3106166T3 (da)	2008-02-29	2021-01-11	Vm Therapeutics Llc	Forbindelser til behandling af smertesyndrom og andre lidelser
EP2542155B1 (de) *	2010-03-01	2015-11-04	TAU Therapeutics LLC	Bildgebungsverfahren einer krankheit

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2061416T3 (es) *	1990-10-12	1997-03-01	Max Planck Gesellschaft	Ribozimas modificadas.

1999
- 1999-08-26 JP JP2000570372A patent/JP2002525077A/ja active Pending
- 1999-08-26 AU AU60217/99A patent/AU6021799A/en not_active Abandoned
- 1999-08-26 CA CA002340586A patent/CA2340586A1/en not_active Abandoned
- 1999-08-26 WO PCT/US1999/019675 patent/WO2000015845A1/en not_active Ceased
- 1999-08-26 EP EP99969121A patent/EP1108068A4/de not_active Withdrawn

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
See also references of WO0015845A1 *
STEA A ET AL: "Voltage-gated calcium channels", 1995, CRC PRESS, BOCA RATON, XP002215487 *
SUSUMO SEIMO ET AL: "Cloning of the alpha1 subunit of a voltage-dependent Calcium channel expressed in pancreatic beta cells", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 89, no. 2, 15 January 1992 (1992-01-15), pages 584 - 588, XP002142249, ISSN: 0027-8424 *
ZHUANG HEAN ET AL: "Cloning of a T-type Ca2+ channel isoform in insulin-secreting cells.", DIABETES, vol. 49, no. 1, January 2000 (2000-01-01), pages 59 - 64, XP002215486, ISSN: 0012-1797 *

Also Published As

Publication number	Publication date
JP2002525077A (ja)	2002-08-13
WO2000015845A1 (en)	2000-03-23
WO2000015845A9 (en)	2001-12-13
EP1108068A1 (de)	2001-06-20
AU6021799A (en)	2000-04-03
CA2340586A1 (en)	2000-03-23

Legal Events

Date	Code	Title	Description
2001-05-05	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2001-06-20	17P	Request for examination filed	Effective date: 20010322
2001-06-20	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2001-06-20	AX	Request for extension of the european patent	Free format text: AL;LT;LV;MK;RO;SI
2002-12-04	A4	Supplementary search report drawn up and despatched	Effective date: 20021018
2002-12-04	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2005-07-22	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2005-09-07	18D	Application deemed to be withdrawn	Effective date: 20050301

Publication	Publication Date	Title
DE69927787D1 (de)	2006-03-02	Kanaldefinitionsarchitekturerweiterung
FR2780269B1 (fr)	2003-10-17	Implant rachidien
FI982690L (fi)	2000-06-12	Kanavaihdon ajoituksen määrittäminen
DE59910409D1 (de)	2004-10-07	Distraktionsvorrichtung
DE59910376D1 (de)	2004-10-07	Schleuderstreuer
FR2775183B1 (fr)	2000-08-04	Prothese inter-epineuse
DE69929656D1 (de)	2006-04-13	Abdichtung
DE59912839D1 (de)	2005-12-29	Distraktionsvorrichtung
DE69927465D1 (de)	2005-11-03	Kanalzuweisungssystem
DE69910462D1 (de)	2003-09-25	Cervicalorthese
DE69935402D1 (de)	2007-04-19	Saugfähiger Gegenstand
DE59906732D1 (de)	2003-10-02	Verstellmechanismus
DE69910832D1 (de)	2003-10-02	Hochverzweigte blockcopolymere
NO20006697L (no)	2001-02-27	Tetning
DE69920345D1 (de)	2004-10-28	Fräsmeissel
DE59913860D1 (de)	2006-11-02	Mittelohrimplantat
DE59811001D1 (de)	2004-04-22	Dichtungseinrichtung
DE69903524D1 (de)	2002-11-21	Pestizide hilfsmittel
DE69917738D1 (de)	2004-07-08	Styrol-Butadien Blockcopolymere
DE19981163T1 (de)	2000-07-20	Propylen-Ethylen Blockcopolymere
EP1108068A4 (de)	2002-12-04	T-typ kalzium kanal
ATA21099A (de)	2005-10-15	Weichensteuerung
ID27962A (id)	2001-05-03	Pembuatan tetrahidrofuran
DE59904981D1 (de)	2003-05-15	Lamellen-bremsklotz
ID26655A (id)	2001-01-25	Pembuatan streptokokus